Viewing Study NCT00366457


Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2026-04-10 @ 7:57 AM
Study NCT ID: NCT00366457
Status: COMPLETED
Last Update Posted: 2017-05-15
First Post: 2006-08-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
Sponsor:
Organization: